Take a look at this tweet, 'year end' is any day now:
$TXTM Protext Pharma taking steps to restructure preferred stock already issued as company contemplates strategic acquisition in emerging cannabis related space. Result would make available approximately 30% of already issued Preferred stock and should be completed by year end.